Humanized antibodies against ICAM-1, their production and uses

Details for Australian Patent Application No. 2002363027 (hide)

Owner Perlan Therapeutics, Inc.

Inventors Charles, Catherine Helen; Luo, GuangXiang; Fang, Fang; Kohlstaedt, Lori Allison

Agent Shelston IP

Pub. Number AU-B-2002363027

PCT Number PCT/US02/23002

PCT Pub. Number WO2003/035696

Priority 09/910,483 19.07.01 US

Filing date 19 July 2002

Wipo publication date 6 May 2003

Acceptance publication date 18 September 2008

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 33/06 (2006.01) Antiparasitic agents

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/02 (2006.01) Mutation or genetic engineering - Preparation of hybrid cells by fusion of two or more cells, e.g. protoplast fusion

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

Event Publications

29 May 2003 Complete Application Filed

  Priority application(s): 09/910,483 19.07.01 US

3 July 2003 Application Open to Public Inspection

  Published as AU-B-2002363027

18 September 2008 Application Accepted

  Published as AU-B-2002363027

8 January 2009 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 13 Nov 2008. Address for service in Australia - Shelston IP 60 Margaret Street Sydney NSW 2000 2003

30 April 2009 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 13 Nov 2008 2003

7 May 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002363028-SYNTHESIS OF SILICOALUMINOPHOSPHATES

2002363026-ADSORPTION ELEMENT AND METHODS